US 11001618
Overexpression of FOXC1 to treat corneal vascularization
granted A61KA61K48/0016A61K48/005
Quick answer
US patent 11001618 (Overexpression of FOXC1 to treat corneal vascularization) held by Northwestern University expires Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Northwestern University
- Grant date
- Tue May 11 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K48/0016, A61K48/005, A61K48/0058, A61K48/0075